- Home
- BNRG vs ENLV Comparison
BNRG vs ENLV Comparison
Compare BNRG & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNRG
- ENLV
- Stock Information
- Founded
- BNRG 2012
- ENLV 2005
- Country
- BNRG Israel
- ENLV Israel
- Employees
- BNRG N/A
- ENLV N/A
- Industry
- BNRG
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- BNRG
- ENLV Health Care
- Exchange
- BNRG Nasdaq
- ENLV Nasdaq
- Market Cap
- BNRG 24.3M
- ENLV 27.3M
- IPO Year
- BNRG 2022
- ENLV 1995
- Fundamental
- Price
- BNRG $1.80
- ENLV $1.13
- Analyst Decision
- BNRG
- ENLV Strong Buy
- Analyst Count
- BNRG 0
- ENLV 2
- Target Price
- BNRG N/A
- ENLV $9.50
- AVG Volume (30 Days)
- BNRG 4.6M
- ENLV 105.9K
- Earning Date
- BNRG 02-27-2025
- ENLV 11-29-2024
- Dividend Yield
- BNRG N/A
- ENLV N/A
- EPS Growth
- BNRG N/A
- ENLV N/A
- EPS
- BNRG N/A
- ENLV N/A
- Revenue
- BNRG $41,000.00
- ENLV N/A
- Revenue This Year
- BNRG N/A
- ENLV N/A
- Revenue Next Year
- BNRG N/A
- ENLV N/A
- P/E Ratio
- BNRG N/A
- ENLV N/A
- Revenue Growth
- BNRG N/A
- ENLV N/A
- 52 Week Low
- BNRG $0.60
- ENLV $0.81
- 52 Week High
- BNRG $6.10
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- BNRG 55.42
- ENLV 42.22
- Support Level
- BNRG $1.73
- ENLV $1.10
- Resistance Level
- BNRG $3.06
- ENLV $1.19
- Average True Range (ATR)
- BNRG 0.49
- ENLV 0.06
- MACD
- BNRG -0.01
- ENLV -0.01
- Stochastic Oscillator
- BNRG 40.28
- ENLV 17.65
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is an Israel-based company. It is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.